Walleye Capital
HAE icon

Walleye Capital’s Haemonetics HAE Stock Holding History

Walleye Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Buy
66,359
+6,411
+11% +$418K 0.02% 994
2025
Q4 		$4.8M Sell
59,948
-99,957
-63% -$6.72M 0.01% 1188
2025
Q3 		$7.79M Sell
159,905
-36,456
-19% -$2.26M 0.03% 664
2025
Q2 		$14.7M Buy
196,361
+124,230
+172% +$8.23M 0.06% 358
2025
Q1 		$4.58M Buy
+72,131
New +$4.91M 0.02% 843
2024
Q4 		– Sell
-2,565
Closed -$206K – 5119
2024
Q3 		$206K Sell
2,565
-2,467
-49% -$199K ﹤0.01% 3987
2024
Q2 		$416K Buy
+5,032
New +$443K ﹤0.01% 3660
2023
Q4 		– Sell
-2,257
Closed -$202K – 5174
2023
Q3 		$202K Buy
+2,257
New +$202K ﹤0.01% 3550
2022
Q2 		– Sell
-4,111
Closed -$260K – 2509
2022
Q1 		$260K Sell
4,111
-3,273
-44% -$178K 0.01% 1389
2021
Q4 		$392K Sell
7,384
-3,037
-29% -$185K 0.01% 1111
2021
Q3 		$736 Buy
+10,421
New +$658K 0.02% 595
2020
Q4 		– Sell
-4,349
Closed -$379K – 1002
2020
Q3 		$379K Buy
+4,349
New +$380K 0.04% 449
2019
Q2 		– Sell
-690
Closed -$60K – 1853
2019
Q1 		$60K Buy
+690
New +$62.8K 0.01% 1172

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Capital's HAE Position: Q1 2026 in Review

Walleye Capital increased its Haemonetics (HAE) stake by 11% in Q1 2026, buying an estimated $418K and bringing the position to 66,359 shares worth $3.74M. The position accounts for 0.02% of the portfolio, ranked #994.

Walleye Capital first reported a position in HAE in Q1 2019 and has held it in 13 quarters since. The position peaked at $14.7M in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Walleye Capital held 66,359 shares of Haemonetics worth $3.74M as of Q1 2026.
  • Walleye Capital bought 6,411 Haemonetics shares in Q1 2026, an estimated $418K.
  • Haemonetics made up 0.02% of Walleye Capital's portfolio in Q1 2026, its #994 holding.
  • Walleye Capital first reported a position in Haemonetics in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Haemonetics position peaked at $14.7M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.